全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2014 

c-3噁二唑硫乙酰腙取代的氟喹诺酮类似物的合成、抗肿瘤活性及构-效关系

, PP. 1694-1698

Keywords: 氟喹诺酮,噁二唑,酰腙,抗肿瘤活性,构-效关系

Full-Text   Cite this paper   Add to My Lib

Abstract:

为寻找氟喹诺酮由抗菌活性转化为抗肿瘤活性的有效策略,基于药效团拼合原理,用噁二唑替代培氟沙星c-3位羧基,功能酰腙基为其修饰基团,设计合成了c-3噁二唑硫乙酰腙目标化合物7a~7o,目标化合物结构经元素分析、1hnmr、ms确证.采用mtt法评价了目标化合物对人肝癌hep-3b细胞株的体外增殖抑制活性.结果表明,15个目标化合物活性均显著高于对照培氟沙星的活性,其中带吸电子取代基化合物的活性高于供电子基团化合物的活性,尤其是含羧基取代基化合物的活性与对照抗肿瘤药物阿霉素相当,表明芳环羧基修饰基的存在有利于提高抗肿瘤活性.

References

[1]  guozr.strategyofmoleculardrugdesign:activityanddruggability[j].actapharmsin(药学学报),2010,45:539-547.
[2]  hugq,houll,wanggq,etal.design,synthesisandantitumoractivityoffluoroquinolonec-3heterocycles:bis-oxadiazolemethylsulfidederivativesderivedfromciprofloxacin[j].actapharmsin(药学学报),2012,47:1017-1022.
[3]  xiesq,chenys,wanggq,etal.partiv.synthesisandantitumorevaluationofs-triazolothiadiazinesandpyrazolos-triazolesderivedfromciproxacin[j].actapharmsin(药学学报),2012,47:66-71.
[4]  wanggq,duannn,caoty,etal.antitumorfluoroqui­nolonec3-isosterederivatives(i)-synthesisandactivityofbis-oxadiazolemethyl-sulfidederivatives[j].chinjapplchem(应用化学),2012,29:769-774.
[5]  kumarr,madhumathibs,nagarajav.molecularbasisforthedifferentialquinolonesusceptibilityofmycobacterialdnagyrase[j].antimicrobagentschemother,2014,58:2013-2020.
[6]  beckde,agamak,marchandc,etal.synthesisandbiologicalevaluationofnewcarbohydrate-substitutedindenoisoquinolinetopoisomeraseiinhibitorsandimprovedsynthesesoftheexperimentalanticanceragentsindotecan(lmp400)andindimitecan(lmp776)[j].jmedchem,2014,57:1495-1512.
[7]  rajulugg,bhojyanaikhs,viswanadhana,etal.newhydroxamicacidderivativesoffluoroquinolones:synthesisandevaluationofantibacterialandanticancerproperties[j].chempharmbull(tokyo),2014,62:168-175.
[8]  hugq,houll,wanggq,etal.synthesisandantitumorandantibacterialactivitiesoffluoroquinolonec-3isosteresi.norfloxacinc-3carbonylhydrazonederivatives[j].jchinapharmuniv(中国药科大学学报),2012,43:298-301.
[9]  zhangf,wangxl,shij,etal.synthesis,molecularmodelingandbiologicalevaluationofn-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazidederivativesaspotentialanticanceragents[j].bioorgmedchem,2014,22:468-477.
[10]  liz,zhanp,liux.1,3,4-oxadiazole:aprivilegedstructureinantiviralagents[j].minirevmedchem,2011,11:1130-1142.
[11]  ningaiahs,bhadraiahuk,doddaramappasd,etal.novelpyrazoleintegrated1,3,4-oxadiazoles:synthesis,characteriza­tionandantimicrobialevaluation[j].bioorgmedchemlett,2014,24:245-248.
[12]  bansals,balam,sutharsk,etal.designandsynthesisofnovel2-phenyl-5-(1,3-diphenyl-1h-pyrazol-4-yl)-1,3,4-oxadia­zolesasselectivecox-2inhibitorswithpotentanti-inflammatoryactivity[j].eurjmedchem,2014,80:167-174.
[13]  effenbergerk,breyers,schobertr.modulationofdoxorubicinactivityincancercellsbyconjugationwithfattyacylandterpenylhydrazones[j].eurjmedchem,2010,45:1947-1954.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133